JILLIAN SINISCALCHI: Open Payments
NPI 1023744919 · LITTLE RIVER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 29 payments from 11 companies in 2025. Trend: 2023 $450 · 2024 $746 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $201 |
| ABBVIE INC. | 9 | $187 |
| Exact Sciences Corporation | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Lilly USA, LLC | 2 | $38 |
| Averitas Pharma Inc. | 1 | $33 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 2 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: Ozempic, QULIPTA, VRAYLAR, Cologuard Collection Kit, QUTENZA, FARXIGA, Wegovy, JARDIANCE.
Industry payments across SC — which companies pay providers there.
